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ABSTRACT 
In order to expand the theoretical base of targeted search for analeptics, 
the awakening and antihypoxic properties of Heterosides-21, 
Heterosides-31 (derivatives of sulfur and nitrogen containing 
heterocycles) were studied and their mechanisms of action were 
established. Sodium thiopental (42 mg/kg) was used to simulate 
suppression of the respiratory and vasomotor centers of the brain. 
Comparative drugs were the combined analeptic sulfocamphocaine 
(SCC) (20 mg/kg) and antihypoxant Piracetam (300 mg/kg). 
The results were obtained on the models of thiopental anesthesia and 
normobaric hypoxia with hypercapnia, the analysis of which allowed: to 
qualitatively and quantitatively assess the awakening, antihypoxic 
activity of the studied substances and classical preparations; their effect 
on the respiratory center of the brain and the behavioral responses of 
animals; theoretically substantiate, experimentally confirm and establish 
aerobic, anaerobic and detoxification mechanisms for the realization of 
effects in various conditions; to formulate the theoretical foundations of 
a targeted search for universal analeptics and antihypoxic drugs, to offer 
an instrumental and methodological complex for their experimental 
reproduction. 
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Introduction. The range of use of analeptic covers almost all spheres of urgent therapy for 
peace and wartime, as well as disaster medicine. The paradox of this group of drugs is that with such a 
high demand, over the past 50 years, their arsenal in the global pharmaceutical market has not only not 
been replenished, but even reduced to 6 drugs (in Ukraine 3), which, due to their peculiarities and 
shortcomings, cannot meet the needs of resuscitation [1]. This is largely due to the lack of 
standardized methods for assessing their effectiveness, understanding of the mechanisms of action, as 
well as the theoretical foundations of targeted search. Therefore, the creation of original broad-
spectrum analeptic agents, the development of standardized models of their pharmacological 
screening, the study of the mechanisms of action is a viable, promising and highly relevant problem.  
Aim of the research is the selection of promising substances with an awakening effect in a 
series of derivatives of sulfur and nitrogen containing heterocycles (heterosides) on the proposed 
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model of thiopental anesthesia (TPA), the study of their antihypoxic properties and mechanisms of 
action to create the theoretical foundations of a targeted search for analeptics. 
Materials and methods. Analeptic (AL) (awakening) and antihypoxic (AH) properties of 
substances were evaluated on male non-linear white mice weighing 25 – 29 g. Sodium thiopental 
(PJSC Kievmedpreparat, Ukraine) was used as an inhibitor of the respiratory and vasomotor centers of 
the brain. This medical preparation is used in medicine and veterinary medicine as an anesthetic drug 
[1,13]. For comparison, classic drugs were chosen - combined analeptic Sulfocamphocaine (SCC) 
(Darnitsa), stimulating the respiratory (RC) and vasomotor (VMC) brain centers [1], as well as 
antihypoxant Piracetam (Halychpharm), prescribed during hypoxia of the central nervous system 
(CNS) [12]. Optimal doses of TPA (42 mg/kg), SCC (20 mg/kg), Heterosides-21 and Heterosides-31 
(2 mg/kg), Piracetam (300 mg/kg) were established experimentally [2-6,9-11, 12]. 
All mice were kept in plastic cages on a standard diet with free access to water in the 
conditions of the Central Research Laboratory of NUPh in accordance with sanitary and hygienic 
norms (t = 18-23°С, humidity not more than 50%, natural light mode “day -night") [7,8]. All studies 
were performed in accordance with the requirements of the General Ethical Principles of Experiments 
on Animals, methodical recommendations of the State Pharmacological Center of the Ministry of 
Health of Ukraine “Preclinical studies of medicines”, “European Convention on the Protection of 
Vertebrate Animals used for experimental and other scientific purposes” (Strasbourg, 1985) and in 
accordance with EU Directive 2010/10/63 EU on animal experiments [8]. 
When studying the awakening effect of the test substances, animals were divided into 5 
groups (n = 6). First, all the intraperitoneal injections were made with TPA [1,6,10]. The first group 
was the control group and received only TPA. The test substances and comparison preparations were 
also administered intraperitoneally after the animals entered the third phase of anesthesia (immobilized 
lateral position with uniform slow breathing), i.e. at the peak of anesthetic sleep (30 - 40 minutes)  
[2-6,9-11]. The second and third groups received the studied substances, namely, Heterosides-21, 
Heterosides-31 [4-6], the fourth group – SCC [2-6,9-11], the fifth – Piracetam [1,6,12]. Analeptic 
efficacy was assessed by reducing the duration of anesthesia (DA).  
Antihypoxic properties were studied under conditions of normobaric hypoxia with 
hypercapnia (NBHH) [7,9] in 5 groups of mice (n = 9-10): 1st control pathology (hypoxia only), the 
2nd and the 3rd group were injected with freshly prepared aqueous solutions of Heterosides-21, 
Heterosides-31, 4th with SCC analeptic, 5th with Piracetam antihypoxant. All substances under study 
and comparison preparations were injected intraperitoneally 15 minutes before the start of the 
experiment [7,9]. The criterion of antihypoxic activity was the duration of life (DL) of mice.  
The effect on RC was determined by the frequency of respiratory movements per minute 
(FRM/min) in different phases of anesthesia before and after the administration of the awakening 
drugs. Indicators DA and FRM/min in mice of the 1st group were considered control, and all other 
experimental groups were compared with them [2-6,9-11]. The FRM were counted for 60 seconds, 
starting immediately with the animals adopting a lateral position (LP) after the introduction of the 
TPA (FRM 1), and the counts were repeated at intervals of ten minutes (respectively, the FRM 2 – 
FRM 9). The introduction of Heterosides-21, Heterosides-31 and SCC in the respective groups was 
carried out at the peak of anesthesia (thirty-first minute) immediately after counting of FRM 4. The 
last FRM measurement was performed after complete awakening of the mice (taking position on four 
legs) [2-6,9-11]. From that moment, their psychomotor state was evaluated (disorientation in space or 
purposefulness of movement); the level of their adaptation after anesthesia (lethargy or hyperactivity, 
interest in food and water); physiological reactions (urination, defecation) and other behavioral 
reactions [4-7]. The reliability of the results obtained was evaluated by the criteria of Newman-Keuls 
and Mann Whitney (Statistica 10.0 program).  
Results and Discussion. Under the experimental conditions, the classic analeptic SCC was the 
most active, which accelerated the awakening of animals at the optimal dose by 32.5% (Table 1). The 
awakening efficacy of Heterosides-21, Heterosides-31 was 28.2 and 27.9%, respectively. Under 
similar conditions, Piracetam on the contrary prolonged anesthesia by 30.3% [1,12]. Thus, 
Heterosides-21, Heterosides-31 at a concentration of 10 times less than SCC practically did not yield 
to him in awakening efficiency, which indicates the promise of derivatives of sulfur and nitrogen 
containing heterocycles to search for original analeptics. 
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Table 1. Awakening effect of the substances under study, (n = 6) 
Groups Average duration of anesthesia 
Awakening  
effect 
р 
TPA (control group) 84 min 41 seс 5081(4949;5290) 100% 0%  
TPA + Heteroside – 21 60 min 47 seс 3647 (3296;3921)* 71.8% -28.2% 0.0022 
TPA + Heteroside – 31 61 min 03 seс 3663 (3592;4213)* 72.1% -27.9% 0.0022 
TPA + 
Sulfocamphocaine  
57 min 12 seс 3432 (2765; 3810)* 67.5% -32.5% 0.0022 
TPA + Piracetam 
110 min 21 seс 6621 (5447; 
7924)*/**/# 
130.3% +30.3% 0.0021 
Notes: 
1. р – the level of statistical significance when comparing samples using dispersion analysis ANOVA, 
2. *– the level of statistical significance when comparing samples of the studied groups with a 
control group using the Mann Whitney test, 
3. ** – the level of statistical significance when comparing samples of a group with groups of 
Heteroside-21 and a group of Heteroside-31 using the Mann Whitney test, 
4. # – the level of statistical significance when comparing samples of a group with a 
sulfocamphocaine group using the Mann Whitney test. 
The behavioral reactions of animals after awakening were symbatic to the type of activity of the studied 
substances. Groups of mice receiving Heterosides-21, Heterosides-31 had good coordination of movements (moving 
in a straight line at a fast pace), actively ate and drank water, and had enhanced diuresis. Mice from the SCC group 
were moving more slowly, along the perimeter of the cage with frequent falls, did not show interest to water and food, 
urination was rare, and then they completely hibernated (lasting for about 1 hour). The animals of the control group 
remained stagnant and disoriented for a long time (they frozed or moved slowly, rolled over from one side to the other, 
carried out circular motions, they completely lost their interest in water and food). After some time, they also fell into a 
long sleep (1-2 hours), which fully coincides with the classic symptoms of TPA intoxication [2-6,9-11].  
Shock, collapse, anesthesia, asphyxia, hypoxia, bacterial intoxication, poisoning with chemical 
compounds or drugs that suppress the functions of the central nervous system, that is, almost all areas 
of urgent therapy associated with the development of local or general hypoxia. In this case, the use of 
analeptics is indicated and logical [1-6,9-11]. Their ability to activate RC and FRM of the brain 
accelerates oxygenation and blood circulation, which contributes to the reduction of local and general 
hypoxia. On this basis, it can be assumed that oxygenation (antihypoxic effect) is one of the most 
important component of the analeptic action. To test this hypothesis, it seemed interesting to 
compare the AL and AH properties of the studied substances. Studies conducted on the NBHH model 
showed that the DL of mice under the action of SCC was extended by 35.5%, under the influence of 
Heterosides-21, Heterosides-31 – by 32.3% and 33.2%, respectively. In the Piracetam group, this 
indicator was only 13.2% higher than the control level (Table 2). 
Table 2. Antihypoxic activity of the substances under study  
Gropus Duration of life, sec р DL, % 
Intact (Control group) (n=9) 24 min 09 sec 1449.2±37.9  100% 
Heteroside–21 (n=10) 31 min 58 sec 1917.6±119.6* 0.0015 132.3% 
Heteroside–31 (n=10) 32 min 11 sec 1930.9±110.6* 0.0021 133.2% 
Sulfocamphocaine (n=9) 32 min 44 sec 1964.0±65.4* 0.0016 135.5% 
Piracetam (n=9) 27 min sec 1641±57.8** 0.0315 113.2% 
Notes: 
1. р – the level of statistical significance when comparing samples using dispersion analysis ANOVA, 
2. – the level of statistical significance when comparing samples of the studied groups with a 
control group using the Newman-Keuls test, 
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3. ** – the level of statistical significance when comparing the sample of the studied group 
with the Heteroside-21 group using the Newman-Keuls test, 
4. n – number of mice in a group. 
The symbasis of the of AH and AL values (awakening) effects in all the studied substances 
confirmed our assumption about the key role of antihypoxic properties for the manifestation of analeptic 
action of the substances, but did not ptovide an idea indication about the mechanism of their 
implementation. According to our ideas, resistance to hypoxia can be increased in four ways: under aerobic 
conditions, by activating of RC and FRM, which accelerates natural oxygenation and blood circulation; 
hypothermic or drug-toxic (anesthesia, anabiosis) suppression of the metabolic activity of tissues; in anaerobic 
– stimulation of endogenous anaerobic mechanisms of energy supply; a combination of these options. 
The rapidity of the NBHH model, the presence of stress, hypercapnic intoxication, and a 
constant amount of residual air initially excluded the possibility of implementing the first and second 
mechanisms of AG activity. Under these conditions, only the third option is possible - activation of 
endogenous anaerobic energy compensation, which, obviously, is provided by the studied 
Heterosides, SCC and Piracetam. 
To study other options for the implementation of the AH effect of the studied substances, the 
model of TPA of anesthesia developed by us [6] was optimally matched, which makes it possible to 
adequately assess their effect on RC and FRM of the CNS in various phases of anesthetic sleep. For this, 
simultaneously with DA, changes in the FRM of animals were recorded. Comparison of the results of FRM 
in different phases of anesthesia (Table 3) showed that after the introduction of TPA, the FRM 1 – FRM 4 
decreases, respectively, from 80; 72.5; 64.5 respiratory movements (RM/min), reaching a minimum of 60.5 
RM/min (peak of anesthesia) in the control group at 30–40th minute of anesthetic sleep.  
Table 3. The effect of the studied substances on the frequency of respiratory movements 
     Groups 
 
FRM 
TPA 
(Control 
group) 
TPA + 
Heteroside–21  
TPA + 
Heteroside–31  
TPA + 
Sulfocam-
phocaine  
 
TPA + 
Piracetam 
р 
FRM 1 80 (72;82)    (n=30) 0.7024 
FRM 2 72.5 (65;75)  (n=30) 0.5548 
FRM 3 64.5 (61;69)   (n=30) 0.4237 
FRM 4 60.5 (58;64)   (n=30) 0.0870 
FRM 5 
58.5(50;60)     
(n=6) 
63(62;65)*  
(n=6) 
63 (62;65)* 
(n=6) 
85 (80;91) 
*/**/# 
(n=6) 
68.5 (67;69) 
*/##  (n=6) 
0.0003 
FRM 6 
59.5(55;64) 
(n=6) 
81.5(81;83)  
(n=6) * 
77(72;83) * 
(n=6) 
80 
(78;83,5)  * 
(n=4) 
72.5 (72;73) 
*/#/ ##   
(n=6) 
0.0013 
FRM 7 
65.5(61;70) 
(n=6) 
77(76;78)  (n=3) 
78(76.5;80.5) 
(n=4) 
(n=0) 
79(76;79) 
(n=6)  
1.0000 
FRM 8 
67.5(66;74) 
(n=6) 
78(78;78) 
 (n=1) 
78(74;82) 
 (n=2) 
(n=0) 
81(79;83) * 
 (n=5) 
1.0000 
FRM 9 
73.5(58;78) 
 (n=6) 
(n=0) (n=0) (n=0) 
82.5(80.5;84)* 
 (n=4) 
1.0000 
FRM 10 (n=0) (n=0) (n=0) (n=0) 
82(81;82) 
 (n=3) 
1.0000 
FRM 11  (n=0) (n=0) (n=0) (n=0) 
81(81;81) 
 (n=2) 
1.0000 
FRM 12 (n=0) (n=0) (n=0) (n=0)* 
78(78;78) 
 (n=1) 
1.0000 
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Notes: 
1. р – the level of statistical significance when comparing samples using dispersion analysis ANOVA, 
2. *– the level of statistical significance when comparing the studied groups with a control 
group using the Mann Whitney test, 
3. ** – the level of statistical significance when comparing samples of the studied groups with 
the Heteroside-31 group using the Mann Whitney test, 
4. # – the level of statistical significance when comparing samples of the studied groups with 
the Heteroside-21 group using the Mann Whitney test, 
5. ## – the level of statistical significance when comparing samples of the studied groups with 
the sulfocamphocaine group using the Mann Whitney test, 
6. n – number of mice in a group, 
7. n = 0 – all the mice in the group are awake. 
After the administration of Heterosides-21, Heterosides-31, SCC and piracetam, during the 
first 10 minutes there was a significant increase in FRM 5 relative to the control group by 7.7%, 7.7%, 
45.3% and 17.1% and through 20 minutes the FRM 6 reached 37; -29.4; -34.2; -21.8%, respectively, 
in all groups. Then indicators of FRM 7-10 stabilized in the range of 77-79% (at the level of FRM 1) 
until the mice are fully awakened. It should be noted that after the introduction of Piracetam, a 
systemic increase in the FRM from 68.5 to 81 RM/min was observed and reached a maximum – 82.5 
RM/min in the FRM 9-10 interval, which exceeded the starting value (80 RM/min) for 20 minutes, but 
was not accompanied by the awakening of animals. 
The analysis of the FRM dynamics under the influence of the studied substances allows us to note 
several interesting facts for the interpretation of the mechanisms of their hypertension and AL effects. 
First, the maximum FRM value (85 RM/min) and the speed of its achievement was observed in the 
SCC group. The speed of RC stimulation (oxygenation) is 37.3% higher than the Heterosides-21, 
Heterosides-31 effect and leads animals to a faster awakening; Secondly, the attainment by animals of the 
Heteroside groups of the starting level of FRM 1 was also accompanied by their awakening. Those and in this 
case, the FRM of the mice (oxygenation rate) correlated with the rate of awakening (Fig. 1). 
 
 
Fig. 1. Dynamics of the respiration rate of the studied substances on the TPA model. 
Thirdly, a comparison of the FRM-7, -8, -9 values indicates that in the control group of mice, even 
after a complete awakening (84 min 41 sec), the FRM was lower (73.5 RM/min) of the starting level  
(80 RM/min). This means that weaker oxygenation of the organs and tissues causes a later awakening. 
Fourthly, Piracetam prolonged anesthesia by 30.3%, exacerbated anesthesia intoxication of TPA 
for 30 minutes, showed a weak antihypoxic effect (13.2%) (Table 1, 2). At the same time, the activity of 
mice RC in this group was not inferior to the level of its activation by Heterosides-21, Heterosides-31 
(FRM 8), SCC (FRM 7) and significantly exceeded control (FRM 9) at the time of awakening of animals 
of the respective groups. This suggests that the ability of substances to influence the metabolism, 
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destruction and elimination of xenobiotics plays a significant role in the realization of AL and AH effects 
(due to the enhancement or suppression of the enzymatic activity of organs and tissues). 
Thus, the mechanism of AL and AH effects of the studied substances depends on the cause of 
hypoxia. In case of oxygen deficiency, they are realized due to the activation of anaerobic energy 
supply, which reduces the tissue demand for oxygen. In aerobic conditions - through the activation of 
the respiratory and vasomotor centers of the central nervous system, accelerating oxygenation and 
blood circulation. In case of CNS poisoning, the significance of their activation of metabolic 
destruction and elimination of xenobiotics increases. 
The results obtained coincide with the classical ideas about the mechanisms of the effects of TPA, 
which inhibit the central nervous system in general and the RC in particular [10]; analeptic SCC [4-6,8-10]; 
clinical symptoms and practice of Piracetam application. This confirms the adequacy of the recommended 
research model, which allows to qualitatively and quantitatively assess the effect of substances on RC of 
the CNS, behavioral reactions and ability to metabolic detoxification of xenobiotics [4-10]. 
Conclusions. Theoretically justified and experimentally confirmed: 
- the model of thiopental anesthesia can serve as a standard for screening selection and 
evaluating the mechanism of action of universal analeptics and antihypoxants;  
- derivatives of sulfur and nitrogen-containing heterocycles are promising for the search for 
universal analeptics and antihypoxants;  
- analeptic effect is determined by the ratio of the complex mechanisms of activation and 
inhibition of metabolic processes in various brain structures. 
REFERENCES 
1. Дроговоз С.М. Фармакология в помощь студенту, провизору и врачу: Учебник-справочник / С.М. 
Дроговоз, С.Ю. Штрыголь, Е.Г. Щекина. – Х.: Титул, 2013. – 900 с. 
2. Кабачна І.В. Детоксицирующее действие Гетерозида-321 при отравлении алкоголем / Кабачная 
И.В., Дроговоз С.М., Кабачный В.И., Палагина Н.Ю., Кабачный В.В.// Наук. журн. Український 
вісник психоневрології. - Том 25, - випуск 2 (91). - Харків, 2017. С. 49-52.  
3. Кабачна І.В. Цілеспрямований пошук оригінальних субстанцій з аналептичною активністю на 
моделі кетамінового наркозу / Кабачна І.В., Дроговоз С.М., Кабачний В.І., Палагина Н.Ю. // Наук. 
журн. «Фармакологія та лікарська токсикологія» - №4-5 (55)/2017. С. 27. 
4. Кабачна І.В., Дроговоз С.М., Кабачний В.І. Патент UA 121609 на корисну модель, МПКG09B 23/00 
(2017.01) / Заявка № и 2017 06266 від 19.06.17 / Спосіб відбору субстанцій для цілеспрямованого 
пошуку оригінальних біологічно активних сполук з аналептичною активністю на моделі 
кетамінового наркозу – № и 2017 06212; заявл. 27.06.2017 №256; опубл. 11.12.2017. – Бюл. №23, 
2017. – 13 с. 
5.  Кабачна І.В., Дроговоз С.М., Кабачний В.І. Патент UA 122200 на корисну модель, МПК 2017.01, 
G01N 33/15 (2006/01), A61D 7/00, A61B 5/11 (2006.01), A61B 5/113 (2006.01) / Заявка № u 2017 
07292 від 11.07.2017 / Спосіб відбору субстанцій для цілеспрямованого пошуку оригінальних 
біологічно активних сполук з аналептичною активністю на моделі алкогольного наркозу – № u 2017 
07292; заявл. 11.07.2017 №283; опубл. 26.12.2017. – Бюл. №24, 2017. – 13 с. 
6. Кабачна І.В., Дроговоз С.М., Кабачний В.І. Патент UA 121609 на корисну модель, МПК G09B 23/00 
(2017.01) / Заявка № u 2018 04154 від 16.04.18 / Спосіб відбору субстанцій для цілеспрямованого 
пошуку оригінальних біологічно активних сполук з аналептичною активністю на моделі 
тіопенталового наркозу – № u 2018 04154; заявл. 16.04.18 №9980/ЗУ/18; – 15 с.  
7. Миронов, А.В. Руководство по проведению доклинических исследований лекарственных средств / 
А.В. Миронов, Н. Д. Бунятян, А. Н. Васильева [и др.] – Москва: Гриф и К, 2012. – 944 с. 
8. Deacon R. M. Housing, husbandry and handling of rodents for behavioral experiments / R. M. Deacon // 
Nature Protocols. – 2006. – V. 1. – № 2. – P. 936–946. 
9. Kabachna I.V. Anti-hypoxic properties of Heteroсide – 321 / Kabachna I.V., Plakhotna E.Yu.// Materials of 
the VIII-National pharmacists congress, Kharkiv, 13-16 September 2016. – P.143. 
10. Kabachna I.V. Awakening action of Heterosides on a model of thiopental anestaesia / Kabachna I.V., 
Storozhenko O.M., Drogovoz S.M., Kabachnyy V.I. // Topical issues of new drugs development: April 18-
20, 2018.: thes., report – Kharkiv. – P. 261-263.  
11. Kabachna I.V., The standartized model of alcohol drugs for certain screening of analeptics / I.V. Kabachna, 
S.M. Drohovoz, V.I. Kabachnyy, Yu.Yu. Serdiukova // Journal of Clinical Pharmacy - 2017. – V.21, № 4 
P. 4-10. ISSN: 1562-725X. 
12. Morana H. The effects of piracetam on cognitive performance in a mouse model of Down’s syndrome 
Timothy // H. Morana, George T. Caponeb, Susan Knippa, Muriel T. Davissonc, Roger H. Reevesd, John 
D./ Gearhart Physiology & Behavior 77 (2002): 403 – 409.  
13. Teresa A. Zimmers Lethal Injection for Execution: Chemical Asphyxiation?/ Jonathan Sheldon; David A. 
Lubarsky; Francisco López-Muñoz; Linda Waterman; Richard Weisman; Leonidas G. Koniaris// PLoS 
Med. 2007;4(4) PLoS Med.© 2007 Public Library of Science. Электронный ресурс, Режим доступа: 
https://www.medscape.com/viewarticle/556167_4  
